| Improved quality of life following constraint-induced movement therapy is associated with gains in arm use, but not motor improvement KM Kelly, AL Borstad, D Kline, LV Gauthier Topics in stroke rehabilitation 25 (7), 467-474, 2018 | 42 | 2018 |
| Evidence for beta corticomuscular coherence during human standing balance: effects of stance width, vision, and support surface JV Jacobs, G Wu, KM Kelly Neuroscience 298, 1-11, 2015 | 40 | 2015 |
| Predicting improved daily use of the more affected arm poststroke following constraint-induced movement therapy MH Rafiei, KM Kelly, AL Borstad, H Adeli, LV Gauthier Physical therapy 99 (12), 1667-1678, 2019 | 38 | 2019 |
| Video game rehabilitation for outpatient stroke (VIGoROUS): A multi-site randomized controlled trial of in-home, self-managed, upper-extremity therapy LV Gauthier, DS Nichols-Larsen, G Uswatte, N Strahl, M Simeo, R Proffitt, ... EClinicalMedicine 43, 2022 | 24 | 2022 |
| Neurofilament levels in CSF and serum in an adult SMA cohort treated with Nusinersen KA Rich, A Fox, M Yalvac, S Heintzman, M Tellez, A Bartlett, S Severyn, ... Journal of neuromuscular diseases 9 (1), 111-119, 2022 | 20 | 2022 |
| Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen WD Arnold, S Severyn, S Zhao, D Kline, M Linsenmayer, K Kelly, M Tellez, ... BMJ neurology open 3 (2), 2021 | 19 | 2021 |
| Safety, tolerability, and effect of nusinersen in non-ambulatory adults with spinal muscular atrophy B Elsheikh, S Severyn, S Zhao, D Kline, M Linsenmayer, K Kelly, M Tellez, ... Frontiers in Neurology 12, 650532, 2021 | 17 | 2021 |
| Safety, tolerability, and effect of nusinersen treatment in ambulatory adults with 5q-SMA B Elsheikh, S Severyn, S Zhao, D Kline, M Linsenmayer, K Kelly, M Tellez, ... Frontiers in Neurology 12, 650535, 2021 | 16 | 2021 |
| Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysis R Sadjadi, K Kelly, AM Glanzman, J Montes, M Linsenmayer, M Tellez, ... Muscle & Nerve 67 (3), 239-243, 2023 | 3 | 2023 |
| Differential impact on motor unit characteristics across severities of adult spinal muscular atrophy KM Kelly, J Mizell, L Bigdeli, S Paul, MA Tellez, A Bartlett, S Heintzman, ... Annals of Clinical and Translational Neurology 10 (12), 2208-2222, 2023 | 1 | 2023 |
| Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy (P3-8.010) FG Castanon, A Deardorff, S Zhao, S Severyn, K Kelly, M Tellez, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Outstripping of Motor Unit Compensation with Disease Severity in Adults with Spinal Muscular Atrophy (P3-8.009) A Deardorff, FG Castanon, S Zhao, K Kelly, M Tellez, S Heintzman, S Kolb, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| The FSHD Composite Outcome Measure (FSHD-COM) is Reliable, Valid, and Measures Disease Progression (S7. 005) K Eichinger, M McDermott, K Higgs, M Walker, L Lewis, W Martens, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Change in Body Mass Index is a Significant Predictor of Change in Patient-reported Function in Adults with Spinal Muscular Atrophy Monitored Over a 10-year Period (P4-13.011) K Kelly, W King, M Linsenmayer, J Reynolds, A Bartlett, M Tellez, J Kissel, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| Collateral sprouting in adults with Spinal Muscular Atrophy varies by functional status (4199) K Kelly, M Tellez, S Kolb, B Elsheikh, W Arnold Neurology 96 (15 Supplement), 2021 | | 2021 |
| Investigating NMJ transmission failure in Adults with Spinal Muscular Atrophy (2362) B Elsheikh, S Kolb, S Severyn, M Linsenmayer, K Kelly, A Bartlett, ... Neurology 94 (15 Supplement), 2020 | | 2020 |
| PND74 MAPPING A QUALITATIVE EXPLORATION OF MEANINGFUL CHANGE IN LATER-ONSET (TYPE II OR III) SPINAL MUSCULAR ATROPHY TO THE HAMMERSMITH FUNCTIONAL MOTOR SCALE EXPANDED (HFMSE) C Burbridge, K Kelly, L Garcia, SD Young, J Montes, NB Johnson, ... Value in Health 22, S284, 2019 | | 2019 |
